Target intelligence / Profile preview

Death associated protein 3 pseudogene 2 (DAP3P2)

Target: DAP3P2
Molecular classification: Other (Pseudogene)

Overview

Death associated protein 3 pseudogene 2 (DAP3P2) is a nonfunctional gene segment that resembles the protein-coding gene DAP3. Pseudogenes such as DAP3P2 arise through gene duplication or retrotransposition events and typically accumulate mutations preventing them from producing functional proteins. While most pseudogenes do not have biological activity, some can act as regulatory RNAs affecting the expression of their parent genes, but there is no evidence for DAP3P2 having such a function specifically[2][8]. DAP3P2 is not considered a therapeutic target, nor is it implicated directly in any disease or drug interaction. The functional version, DAP3, is involved in mitochondrial function and apoptosis, and has relevance for cancer biology, but this does not apply to the pseudogene DAP3P2[1][3][7].

Other names: DAP3P2Death Associated Protein 3 Pseudogene 2

Mechanism of action

none relevant — No mechanism of action for drugs applies, due to lack of protein product and direct biological function

Biological functions

Pseudogenes typically do not encode proteins but may have regulatory functions such as acting as long non-coding RNAs or influencing gene expression through mechanisms like RNA interference

Disease associations

While pseudogenes like DAP3P2 are generally not directly involved in disease, some pseudogenes can have regulatory effects contributing to disease development by modulating expression of their parent genes

Beyond the preview

Go deeper on Death associated protein 3 pseudogene 2 (DAP3P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Death associated protein 3 pseudogene 2 (DAP3P2).

Explore the full profile